|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling and administrative expenses | |||||
| Goodwill, Impairment Loss | |||||
| Operating income | |||||
| Interest and other non-operating expenses, net | |||||
| Income before income taxes and equity in earnings | |||||
| Provision for income taxes | |||||
| Equity earnings in unconsolidated investments, net | |||||
| Net income | |||||
| Earnings per share attributable to common stockholders: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Cash dividends declared per common share | |||||
Loading...